New HIV injection tested for safety in early human trial
NCT ID NCT06560489
Summary
This early-stage study tested the safety of a new HIV drug called LP-98, given as injections under the skin. It involved 40 people with HIV who had not yet started treatment. Researchers checked for side effects and measured how the drug moved through the body at different doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial Hospital for Infectious Diseases (Zhengzhou Sixth People's Hospital)
Zhengzhou, Henan, China
Conditions
Explore the condition pages connected to this study.